Hydatid Disease of Bone (Skeletal Echinococcosis)

Organism. Echinococcus granulosus (cystic echinococcosis) causes almost all skeletal disease. E. multilocularis (alveolar echinococcosis) rarely involves bone but when it does behaves like an infiltrative malignancy without cyst walls at all.

Life cycle. The definitive host is the dog (and other canids), harbouring the adult tapeworm. Eggs are passed in faeces and ingested by an intermediate host — classically sheep, also goats, cattle, camels. Humans are accidental dead-end intermediate hosts, infected by hand-to-mouth contact with dog faeces or contaminated water and vegetables. Home slaughter of sheep with offal fed to dogs perpetuates the cycle.

Pathogenesis in humans. The oncosphere penetrates the duodenal mucosa, enters portal blood and is filtered first by the liver (around two-thirds of cases), then lung. Embryos escaping both filters seed systemically — bone accounts for only a small percentage of cases but a disproportionate share of morbidity.

Endemic regions. Mediterranean basin (Türkiye, Greece, Italy, Spain, North Africa), Middle East and Levant, Central Asia and western China, the Indian subcontinent, East Africa, and South America (Argentina, Peru, Uruguay, Chile). Diaspora and migration mean any surgeon anywhere may meet the disease — a patient who grew up herding sheep two decades ago remains at risk, because incubation is measured in years to decades.

Public health framing. Cystic echinococcosis is a WHO-listed neglected tropical disease. Control programmes rest on dog deworming with praziquantel, restricting home slaughter, offal disposal and livestock vaccination — surgical services alone never control the disease.

Tempo. Insidious. Median symptom duration before diagnosis is commonly measured in months to years. Any 'benign-looking' lytic lesion with a two-year history in an endemic-region patient deserves the thought.

Typical complaints by site

Systemic features. Usually absent. Fever suggests secondary bacterial infection. Urticaria, wheeze or a documented anaphylactoid episode after minor trauma or a previous procedure is a strong clue to cyst rupture.

Examination discipline.

• Inspect the whole limb and trunk for old scars and sinuses — most patients are on their second or third episode.
• Palpate for a soft, non-tender, fluctuant paraspinal or gluteal mass.
• Full neurological examination with documented ASIA grade in spinal disease; record sphincter function and perianal sensation before any surgery.
• Examine the abdomen and request chest imaging: coexistent hepatic or pulmonary cysts are present in a substantial minority and change anaesthetic and systemic planning.

Benzimidazoles. Albendazole is first line; it is better absorbed and achieves higher tissue levels than mebendazole. Absorption is fat-dependent — give with a fatty meal. Praziquantel is sometimes added perioperatively for its protoscolicidal effect.

Role.

• Neoadjuvant: for several days to weeks before surgery to reduce cyst turgor and sterilise the contents, lowering the consequence of spillage.
• Adjuvant: continued for months after surgery — commonly cycles or continuous therapy for many months to years in skeletal disease, longer than the standard hepatic regimens because the residual microscopic burden is greater.
• Palliative: sole therapy for unresectable disease (extensive pelvic or multilevel spinal involvement, or the unfit patient), where it suppresses but does not eradicate.

Monitoring. Baseline and periodic full blood count and liver function — the recognised toxicities are hepatitis, leucopenia and alopecia. Avoid in pregnancy (teratogenic in animal models). Counsel on contraception.

Honest framing for the exam. Albendazole alone will not cure bone hydatid. Radiological response in bone is slow and often absent; do not use imaging stability as proof of cure.

Decision thresholds

PIPADRAW — wide excision of an extremity lesion (proximal femur exemplar)

Spinal disease — modifications

• Goal hierarchy: neurological decompression greater than mechanical stability greater than oncological margin. A true en-bloc spondylectomy with clear margins is rarely achievable and carries formidable risk; most series describe piecemeal but maximal excision.
• Approach chosen by disease location: posterior decompression and instrumentation for posterior element and epidural disease; anterior or combined for vertebral body destruction with corpectomy and cage or strut reconstruction.
• Protect the dura from scolicidal agents — do not irrigate hypertonic saline against exposed dura or nerve roots (risk of chemical neuritis and arachnoiditis); use normal saline in the canal and reserve hypertonic lavage for the extradural bony bed.
• Instrument beyond the involved levels into uninvolved bone; expect to revise as disease progresses.
• Counsel explicitly: this is disease control, not cure, with recurrence in a third or more of patients and cumulative neurological deterioration over decades.

• Skeletal hydatid is best conceptualised as a chronic relapsing surgical disease, not an infection that is cured with a course of drugs.
• After wide en-bloc resection with clear margins plus prolonged albendazole, long-term disease-free survival is achievable — this is the only route to cure.
• After intralesional surgery, recurrence is close to universal, often at 2 to 5 years.
• Spinal disease relapses in a third or more even after aggressive surgery, with cumulative neurological decline over decades in some patients.
• Surveillance: clinical review with MRI of the operated region, initially at 6 to 12 month intervals and thereafter annually or biennially, continued indefinitely. Include liver and lung imaging periodically.
• Counselling points: decades-long follow-up, possibility of further surgery, the reality that amputation may ultimately give better function than repeated salvage, contraception advice during albendazole, and household and community measures (dog deworming, avoiding feeding offal to dogs, hand hygiene, washing produce) to protect family members.

Global burden. Cystic echinococcosis is endemic on every inhabited continent where sheep and dogs coexist. WHO includes it among the neglected tropical diseases targeted for control; the highest human incidence figures come from pastoral communities in Central Asia, western China, the Andean region, North and East Africa and parts of the Mediterranean.

Society and body guidance — what genuinely applies

Registries. There is no implant registry evidence specific to hydatid reconstruction. Where endoprostheses are used, the relevant data are the general bone tumour endoprosthesis outcomes from national joint registries and tumour databases: revision is driven by infection and aseptic loosening, and infection risk in a previously contaminated or multiply operated field is higher than in primary sarcoma resection. Counsel accordingly.

Practice variation by resource setting

• High-resource, non-endemic centres see the disease rarely and misdiagnose it commonly; the failure mode is an unplanned biopsy or curettage of an assumed ABC or GCT. Mitigation: geographic history in every lytic-lesion clerking.
• High-resource endemic centres (Türkiye, Spain, Greece, Argentina, Iran) have mature pathways — serology, MRI, tumour-unit resection, endoprosthetic reconstruction, prolonged albendazole with pharmacy monitoring.
• Resource-limited endemic settings face late presentation with huge pelvic or multilevel spinal disease, limited MRI access, intermittent albendazole supply and no endoprosthetic reconstruction. Here amputation, resection arthroplasty, arthrodesis and cement-augmented reconstruction are legitimate, dignified, function-preserving answers, and continuous drug supply is often the binding constraint on outcome.
• Migration effect. Present in any country; incubation of years to decades means childhood exposure explains adult presentation far from the endemic region.

1. Duration of albendazole. No trial defines the optimal postoperative course in bone. Practice ranges from three to six months to continuous multi-year therapy after incomplete excision. Longer courses are widely used in spinal disease on pathophysiological grounds, balanced against hepatotoxicity and adherence.
2. Choice of scolicidal agent. Hypertonic saline, povidone-iodine, ethanol and silver nitrate have all been used. Comparative data are weak. Contact time is probably more important than agent. Formalin is abandoned; agents must not contact dura, nerve or a biliary communication.
3. En-bloc spondylectomy versus maximal piecemeal excision. True Tomita-style en-bloc resection offers the best oncological logic but carries very high morbidity in a benign parasitic disease. Most units accept piecemeal excision plus instrumentation and prolonged drug therapy; the trade-off is unresolved.
4. Amputation threshold. For extensive limb disease, early amputation may deliver cure and better function than repeated failed limb-salvage procedures. Timing this conversation is one of the hardest judgements in the disease.
5. Role of any percutaneous therapy in bone. Occasional reports describe image-guided aspiration and instillation for soft-tissue components. This should be regarded as palliative and non-standard; there is no accepted percutaneous cure for intraosseous disease.
6. Definition of cure. Because vesicles are microscopic and imaging response is slow, no reliable test of cure exists. Serological titres fall unpredictably. Most authorities treat this as a chronic relapsing condition requiring indefinite surveillance rather than a curable infection.
7. Reconstruction choice in a contaminated field. Whether to use massive allograft or biological reconstruction after a case complicated by intraoperative spillage is contested; many prefer cement and metal for their resistance to colonisation and revisability.